- Who can participate: Adults aged 18-65 with a diagnosis of chronic pain lasting more than six months are eligible. Participants must not have any other significant health conditions and should not be currently participating in another clinical trial.
- Study details: Participants will be randomly assigned to receive either the investigational treatment or a placebo. The study involves regular assessments of pain levels, physical examinations, and completion of questionnaires.

